About Epiontis
Epiontis is a company based in Berlin (Germany) founded in 2003 was acquired by Precision Medicine Group in October 2017. The company has 2,141 employees as of December 31, 2021. Epiontis operates in a competitive market with competitors including Parse Biosciences, Biofidelity, RareCyte, Qiagen and RainDance, among others.
- Headquarter Berlin, Germany
- Employees 2141 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Precision Medicine Group, Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
2141
as on Dec 31, 2021
-
Acquired by
Precision Medicine Group
(Oct 04, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Epiontis
Detailed funding history for Epiontis
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Epiontis
Epiontis has secured backing from 1 investor. Prominent investors backing the company include Precision Medicine Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of clinical research, development, and commercialization services for life sciences
|
Locked | Locked | Locked |
Investor details for Epiontis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Epiontis
Investment portfolio details for Epiontis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Epiontis
Detailed financials for Epiontis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Epiontis Comparisons
Peer comparison for Epiontis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Epiontis
Epiontis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Parse Biosciences, Biofidelity, RareCyte, Qiagen and RainDance, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
RNA-sequencing transcriptome kits for health data analysis are developed.
|
|
| Locked | Locked | Locked |
Molecular diagnostic assays are developed for target DNA sequence detection.
|
|
| Locked | Locked | Locked |
Developer of technologies for the analysis of rare and single cells in the blood
|
|
| Locked | Locked | Locked |
Products and reagents for molecular diagnostic assays are supplied.
|
|
| Locked | Locked | Locked |
Developer of nucleic acid detection and quantification systems
|
|
| Locked | Locked | Locked |
Electrophoresis-based in vitro diagnostics products are developed and provided.
|
Detailed competitors of Epiontis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Epiontis
Complete news archive for Epiontis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Epiontis
Epiontis was founded in 2003.
Epiontis is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.
As of Dec 31, 2021, the latest employee count at Epiontis is 2,141.
Epipontis provides solutions for epigenetic cell counting by designing immuno-assays targeting euchromatin DNA of the cell. The designed assays are PCR-based targeting the epigenetically active alleles. The company offers services in a wide range of assays based on their technology such as Regulatory T cells, TH17 cells, Tfh cells, CD4 T cells, CD8 T cells, Naive CD8 T cells, Overall T cells (CD3), B cells, NK cells, (CD56 dim) CCR6, Granulysin Neutrophil, Granulocytes Basophil, and Granulocytes Monocytes.
Epiontis's top competitors include Neogen, Qiagen and Parse Biosciences.
Epiontis has 1 investor. Key investors include Precision Medicine Group.